Medicine
Mon Sep 14, 2020 11:18
Antibody Test Developed for COVID-19 That Is Sensitive, Specific, Scalable
TEHRAN (FNA)- An antibody test for the virus that causes COVID-19, developed by researchers at The University of Texas at Austin in collaboration with Houston Methodist and other institutions, is more accurate and can handle a much larger number of donor samples at lower overall cost than standard antibody tests currently in use. In the near term, the test can be used to accurately identify the best donors for convalescent plasma therapy and measure how well candidate vaccines and other therapies elicit an immune response.

Additional uses coming later that are likely to have the biggest societal impact, the researchers say, are to assess relative immunity in those previously infected by the SARS-CoV-2 virus and identify asymptomatic individuals with high levels of neutralizing antibodies against the virus.

The UT Austin research team, led by Jason Lavinder, a research associate in the Cockrell School of Engineering, and Greg Ippolito, assistant professor in the College of Natural Sciences and Dell Medical School, developed the new antibody test for SARS-CoV-2 and provided the viral antigens for this study via their UT Austin colleague and collaborator, associate professor Jason McLellan. Other UT Austin team members are Dalton Towers and Jimmy Gollihar. The work was published this week in The Journal of Clinical Investigation.

"This is potentially game-changing when it comes to serological testing for COVID-19 immunity," Lavinder said. "We can now use highly scalable, automated testing to examine antibody-based immunity to COVID-19 for hundreds of donors in a single run. With increased levels of automation, limited capacity for serological testing can be rapidly addressed using this approach."

The gold standard of COVID-19 antibody testing measures the amount of virus neutralizing (VN) antibodies circulating in the blood, because this closely correlates with immunity. However, this kind of antibody testing is not widely available because it's technically complex; requires days to set up, run and interpret; and needs to be performed in a biosafety level 3 laboratory.

The research team, therefore, looked to another type of test, called ELISA assays, that can be implemented and performed with relative ease in a high-throughput fashion and are widely available and extensively used in clinical labs across the world. The ELISA tests, or enzyme-linked immunosorbent assays, look at whether antibodies against specific SARS-CoV-2 proteins are present and produce a quantitative measure of those antibodies.

The goal of the study was to test the hypothesis that levels of antibodies that target two regions of the virus's spike protein -- spike ectodomain (ECD) and receptor binding domain (RBD) -- are correlated with virus neutralizing antibody levels, making these more accessible, easier-to-perform ELISA tests a surrogate marker to identify plasma donors with antibody levels above the recommended U.S. Food and Drug Administration threshold for convalescent plasma donation.

In collaboration with UT Austin, Penn State University and the U.S. Army Medical Research Institute of Infectious Diseases, study authors James M. Musser, M.D., Ph.D., and Eric Salazar, M.D., Ph.D., physician scientists at Houston Methodist, used the new test to evaluate 2,814 blood samples used in an ongoing study of convalescent plasma therapy. Houston Methodist became the first academic medical center in the nation to transfuse plasma from recovered individuals into COVID-19 patients.

The researchers found that the ELISA tests had an 80% probability or greater of comparable antibody level to VN levels at or above the FDA-recommended levels for COVID-19 convalescent plasma. These results affirm that all three types of tests could potentially serve as a quantitative target for therapeutic and prophylactic treatments.

Ultimately, the study successfully concluded that anti-RBD or anti-ECD antibody levels can serve as a surrogate for VN levels to identify suitable plasma donors and that these alternate ELISA tests may provide critical information about COVID-19 immunity.

"This research required a perfect storm at the university, which included the extraordinary combination of a world-famous coronavirus structural biology lab, a nimble and passionate visiting army scientist, and the highest echelons of the university's administration who were committed to bringing our extensive research programs to bear on the COVID-19 crisis," Ippolito said.

This study was supported by funding from the National Institutes of Health, the Fondren Foundation, the National Institute of Allergy and Infectious Diseases, the Army Research Office, Houston Methodist Hospital, Houston Methodist Infectious Diseases Research Fund, Houston Methodist Research Institute and seed funding from the Huck Institutes of the Life Sciences for the studies at Penn State, together with the Huck Distinguished Chair in Global Health award. Funding was also provided through the CARES Act, with programmatic oversight from the Military Infectious Diseases Research Program.

 

 

 

Bottom top
COVID-19 Infection Rates in 20 London Boroughs Higher Than Areas of England Already Hit by Restrictions

TEHRAN (FNA)- COVID infection rates in 20 London boroughs are higher than areas of England already hit by restrictions, new data revealed on Monday, as London Mayor Sadiq Khan met council leaders to demand a new lockdown and rush hour traffic dropped five percent.
Military Warns Taiwan’s Armed Forces Have ‘Right to Counter Attack' After China’s Large-Scale Drills

TEHRAN (FNA)- Taiwan’s Defense Ministry announced on Monday that the island’s armed forces have a right to defend themselves and counter attack, citing “harassment and threats” in a warning to Beijing.
Iran Reports 3,341 New Coronavirus Cases, 177 Deaths

TEHRAN (FNA)- The Iranian health ministry announced on Monday that 3,341 new cases of coronavirus infection have been identified across the country during the past 24 hours, adding that 177 patients have passed away during the same period.
Iran’s Deputy Judiciary Chief: Israel Not to Show Mercy to Arab States

TEHRAN (FNA)- Iran's Deputy Judiciary Chief for International and Human Rights Affairs Ali Baqeri warned the Arab states which have normalized ties with Tel Aviv that Israel will soon victimize them for its hegemonic policies.
536 Tons of Illicit Drugs Seized in Iran in 6 Months

TEHRAN (FNA)- Iranian police confiscated nearly 536 tons of various types of narcotics during the first half of the current year (March 20-September 21), Commander of Iran’s Anti-Narcotics Police Brigadier General Majid Karimi said on Monday.
Qatar Affirms Its Position on Palestinian Issue

TEHRAN (FNA)- Qatar on Sunday said it stands by Palestinians and that the long-standing conflict with Israel should be resolved by addressing its root causes, according to the country's official news agency.
Palestinian Women Allege Sexual Abuse in Israeli Jails

TEHRAN (FNA)- Dena Karmi, 41, a Palestinian woman, who spent 16 months in Israeli prison recalls a harrowing tale of sexual abuse, she faced behind the bars, according to a report.
Thousands March at Coronavirus Skeptics Rally in Germany's Dusseldorf

TEHRAN (FNA)- Thousands of people attended a protest on Sunday in the Western German city of Dusseldorf against government restrictions imposed to combat the COVID-19 pandemic.
Thousands of Israelis in First Protests Since Renewed Lockdown

TEHRAN (FNA)- Thousands of Israeli protesters gathered Sunday in Jerusalem to demand the resignation of Prime Minister Benjamin Netanyahu, the first such demonstrations since the start of a new nationwide coronavirus lockdown.
Iran, Hungary Underline Scientific Cooperation

TEHRAN (FNA)- Iranian and Hungarian officials emphasized further cooperation in various scientific fields amid the coronavirus epidemic.
IRGC Aerospace Force Commander Downplays US “Hollow” Threats against Iran

TEHRAN (FNA)- Commander of the Islamic Revolution Guards Corps (IRGC) Aerospace Force Brigadier General Amir Ali Hajizadeh blasted US President Donald Trump’s hollow threats against Iran, saying that Washington is not able to do anything in practice.
MP Urges All Nations to Oppose US Bullying

TEHRAN (FNA)- Member of the Iranian parliament Mohammad Saleh Jokar criticized feeble stances against American bullying, calling on all countries to counter the United States to secure their sovereignty and independence.
FM Zarif: Iran Ready to Broaden Cooperation with World Countries

TEHRAN (FNA)- Iranian Foreign Minister Mohammad Javad Zarif voiced his country's readiness to expand bilateral relations and mutual cooperation with friendly countries of the world.
Iranian Researchers Introduce Inhibitor, Suppressor of Colorectal Cancer Tumors

TEHRAN (FNA)- Iranian researchers at the Royan Institute in cooperation with their colleagues at Tarbiat Modares University identified a gene as the inhibitor of colorectal cancer tumors.
Lawmaker: Power-Hungry Trump’s Threats Aimed at Re-Election

TEHRAN (FNA)- Iranian lawmaker slammed the recent threats posed by the US against Iran, saying that US President Donald Trump has resorted to threatening in a bid to guarantee his reelection in the upcoming presidential elections.